CN108785411A - A kind of Preparation method and use of the cherry powder of control diabetes - Google Patents
A kind of Preparation method and use of the cherry powder of control diabetes Download PDFInfo
- Publication number
- CN108785411A CN108785411A CN201810731443.6A CN201810731443A CN108785411A CN 108785411 A CN108785411 A CN 108785411A CN 201810731443 A CN201810731443 A CN 201810731443A CN 108785411 A CN108785411 A CN 108785411A
- Authority
- CN
- China
- Prior art keywords
- cherry
- preparation
- fermentation
- powder
- cherry powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000167854 Bourreria succulenta Species 0.000 title claims abstract description 103
- 235000019693 cherries Nutrition 0.000 title claims abstract description 103
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 35
- 239000000843 powder Substances 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 238000000855 fermentation Methods 0.000 claims abstract description 37
- 230000004151 fermentation Effects 0.000 claims abstract description 37
- 238000000034 method Methods 0.000 claims abstract description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 7
- 238000004821 distillation Methods 0.000 claims abstract description 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 17
- 239000011347 resin Substances 0.000 claims description 17
- 229920005989 resin Polymers 0.000 claims description 17
- 235000014101 wine Nutrition 0.000 claims description 15
- 230000002745 absorbent Effects 0.000 claims description 14
- 239000002250 absorbent Substances 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 14
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 229940088598 enzyme Drugs 0.000 claims description 13
- 230000006837 decompression Effects 0.000 claims description 11
- 230000000694 effects Effects 0.000 claims description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- 230000001476 alcoholic effect Effects 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 238000005292 vacuum distillation Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 5
- 239000002054 inoculum Substances 0.000 claims description 5
- 239000011975 tartaric acid Substances 0.000 claims description 5
- 235000002906 tartaric acid Nutrition 0.000 claims description 5
- 108010059892 Cellulase Proteins 0.000 claims description 4
- 229940106157 cellulase Drugs 0.000 claims description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 3
- 108010089934 carbohydrase Proteins 0.000 claims description 3
- 230000006378 damage Effects 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- -1 xylosidase Proteins 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- 238000001694 spray drying Methods 0.000 claims description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 16
- 235000016709 nutrition Nutrition 0.000 abstract description 14
- 230000035764 nutrition Effects 0.000 abstract description 12
- 102000004877 Insulin Human genes 0.000 abstract description 8
- 108090001061 Insulin Proteins 0.000 abstract description 8
- 229940125396 insulin Drugs 0.000 abstract description 8
- 230000036541 health Effects 0.000 abstract description 7
- 235000013305 food Nutrition 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 3
- 230000009471 action Effects 0.000 abstract description 3
- 239000008280 blood Substances 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 238000006243 chemical reaction Methods 0.000 abstract description 3
- 235000020104 cherry wine Nutrition 0.000 abstract description 3
- 239000008103 glucose Substances 0.000 abstract description 3
- 230000000144 pharmacologic effect Effects 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- 238000011031 large-scale manufacturing process Methods 0.000 abstract 1
- 235000021022 fresh fruits Nutrition 0.000 description 10
- 235000010208 anthocyanin Nutrition 0.000 description 8
- 229930002877 anthocyanin Natural products 0.000 description 8
- 239000004410 anthocyanin Substances 0.000 description 8
- 150000004636 anthocyanins Chemical class 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 235000013399 edible fruits Nutrition 0.000 description 7
- 206010013786 Dry skin Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 239000000654 additive Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- DLMOVPAUHQQYHA-UHFFFAOYSA-N 5,7-dihydroxy-2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)chromen-4-one Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1(O)C=CC(=O)C=C1 DLMOVPAUHQQYHA-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010089308 Insulin Detemir Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000015120 cherry juice Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002497 edematous effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 229960003948 insulin detemir Drugs 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- UGOZVNFCFYTPAZ-IOXYNQHNSA-N levemir Chemical compound CCCCCCCCCCCCCC(=O)NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=2N=CNC=2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=2N=CNC=2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=2C=CC=CC=2)C(C)C)CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)CSSC[C@H](NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC2=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H](CSSC1)C(=O)N[C@@H](CC(N)=O)C(O)=O)CC1=CC=C(O)C=C1 UGOZVNFCFYTPAZ-IOXYNQHNSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/13—Preparation or pretreatment of starting material involving cleaning, e.g. washing or peeling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to a kind of Preparation method and uses of the cherry powder of control diabetes,It is characterized in that the preparation process of cherry powder includes broken,Fermentation,Distillation,Parsing-desiccation,The present invention is due to using preparation method,Not only having obtained can be with expelling wind and eliminating dampness,The cherry wine of promoting blood circulation and stopping pain,And,During the fermentation,In the case that other nutrition of fresh cherry are not destroyed,The part sugar contained in fresh cherry is become alcohol by conversion to be precipitated,Obtain diabetes patient can courageously eat it is full of nutrition,And insulin can be promoted to generate,Reduce the cherry powder of blood glucose,The present invention has simple for process,Comprehensively utilize raw material,Product is more,High income,It is at low cost,The advantages that suitable for large-scale production,And for controlling diabetes,In treatment diabetes,Prevention and cure of cardiovascular disease etc. has bioactivity outstanding and pharmacological action,The present invention is suitable for food,The fields such as health products.
Description
Technical field
It is specifically a kind of to be prepared using cherry for improving insulin the present invention relates to biological health technical field
Control the Preparation method and use of the cherry powder of diabetes.
Background technology
Currently, medically, the Major Clinical parting to diabetes is doctor trained in Western medicine and Chinese medicine, and the so-called diabetes of doctor trained in Western medicine are divided into pancreas islet
Two kinds of plain dependence and non-insulin-depending type, and the so-called diabetes parting of Chinese medicine be above disappear, in disappear, under disappear three kinds, it is so-called on
It refers to dry-heat impairing lung type to disappear, in disappear refer to stomach energy leaching hinder type, under disappear refer to kidney deficiency card and syndrome of deficiency of both yin and yang two types, and
And diabetes patient due to nutrient absorption it is incomplete, it is easy to cause complication, as cardiovascular pathological changes, knowledge disease, sore ulcer
Deng, therefore, dietary therapy be treat diabetes base therapy, be the premise of all therapies, be suitable for various diabetes
People.Light-duty case can receive preferable effect, Medium or severe type patient, currently, must be on the basis of dietetic treatment based on dietotherapy
On, reasonable drug application therapy carries out auxiliary treatment, controls the raising of blood glucose, it can be seen that, choose diabetic
The nutrition intake health care of food, control and other body parts to diabetes is very important.
It is well known that cherry tree belongs to rose family machaka fruit tree, fruit cherry contains abundant nutrition, first, containing
There is abundant ferro element, iron-holder is located at first of various fruit, and iron is the raw material of synthesized human hemoglobin, myoglobins,
Durings human immunity, protein synthesis and energetic supersession etc., play an important role, at the same also with brain and neural work(
The close relations such as energy, aging course.Often feeding cherry can supplement the demand to ferro element amount in vivo, promote hemoglobin again
It is raw, hypoferric anemia can be not only prevented, but also can build up health, brain tonic and intelligence development；Second is that prevention measles, when Measles Epidemic, gives children's drink
It can prevent to infect with cherry juice.Cherry stone then has the function of the removing toxic substances of sweating promoting eruption；Third, expelling wind and eliminating dampness, desinsection, cherry
Warm, has both the work(of tonifying middle-Jiao and Qi, and energy dispelling wind and eliminating dampness has good effect to rheumatic lumbocrural pain pain.Cherry tree root also has very strong drive
Worm, insecticidal action can kill roundworm, pinworm, tapeworm etc..Not only edible value is very high for cherry, but also the work of also Dietotherapy health
With, such as insufficiency of the spleen diarrhoea, tonifying middle-Jiao and Qi, expelling wind and eliminating dampness, kidney deficiency lumbocrural pain, activity it is ineffective.
Due to Cherry i s of high nutrition, in the prior art, has and extracts Vc from cherry, also have and extract anthocyanin from cherry,
When extracting anthocyanin, water extraction or alcohol extracting method are mostly used, nutrition is single, only anthocyanin, and other abundant in cherry
Nutrition to being discarded, such as：The U.S. has researcher to extract anthocyanin from cherry recently, and is taken out out of rodent body
The pancreatic cell of insulin is manufactured, effect of the detection anthocyanin to these cells, after contacting anthocyanin, the insulin of cell generates
Half can be increased, this illustrates that the anthocyanin in cherry has diabetes certain curative effect, deficiency to be：Extract component is single, no
Conducive to the nutrition intake of diabetes patient.Since cherry is not belonging to drug, also, cherry does not contain merely to insulin promotion growth
Anthocyanin and procyanidine constituents, also contain abundant vitamin C, vitamin B complex（VB1, VB2, VB6, Nicotine are plain, general
Acid）, vitamin E, minerals（Calcium, copper, iron, potassium, manganese, sodium, sulphur, zinc, magnesium）With Protoapigenone (Flavonoids), sugar, Chinese holly
Rafter acid, tartaric acid etc., the combination of various nutritional ingredients have middle regulating and qi tonifying, strengthening the spleen and stomach, wind-damp dispelling and other effects to body.
Since cherry belongs to seasonal fruit, it is unable to long-term preservation under room temperature, therefore, how diabetes patient can be allowed to eat at any time
The upper this fruit that can improve islet function is at present in the world all in a great problem captured.
Invention content
A kind of that the object of the present invention is to provide preparation methods is simple, nutritional ingredient is more, promotes insulin generation has and adjusts
The Preparation method and use of middle QI invigorating, the cherry powder of the control diabetes of strengthening the spleen and stomach, wind-damp dispelling.
The technical solution adopted by the present invention to solve the technical problems is：
A kind of preparation method of the cherry powder of control diabetes, it is characterised in that the preparation process of cherry powder include broken, fermentation,
Distillation, parsing-desiccation,
Wherein, the destruction step：Take fresh cherry, cherry cleans up rear drained, is put into crusher and is broken
Broken processing；
The fermentation step：Biological enzyme is added into broken cherry to be digested, after enzymolysis, is stood sealing and fermenting,
Obtain cherry former wine fermentation liquid；
The distilation steps：Cherry former wine fermentation liquid is placed in vacuum distillation pot and is distilled, cherry former wine is fermented molten
After alcohol in liquid all distills proposition, cherry schlempe solution and Spirit are obtained；
The parsing-desiccation step：Cherry schlempe solution is adsorbed by macroporous absorbent resin, macroporous absorbent resin is washed with water
Afterwards, then with alcoholic solution it parses, obtains desorbed solution, then desorbed solution low temperature is concentrated, vacuum decompression drying obtains cherry powder.
Biological enzyme in fermentation step of the present invention is one kind or more of pectase, cellulase, xylosidase, carbohydrase
Kind, when enzymolysis, enzyme activity requires more than 5000 units.
Fermentation temperature in fermentation step of the present invention can be at 20~30 DEG C, and fermentation time can be 1~8 day, and yeast adds
Dosage is 0.1~0.5 ‰, and citric acid or tartaric acid may be used in the adjustment of fermentating liquid PH value.
When vacuum distillation in distilation steps of the present invention, pressure is -0.01~-0.1mpa, and heating temperature is with going out
Wine situation changes, and may be provided within the scope of 30~60 DEG C.
Macroporous absorbent resin in parsing-desiccation step of the present invention is non-polar resin, or low pole tree
Fat.
The low temperature method for concentration of desorbed solution in parsing-desiccation step of the present invention is normal pressure, or is recovered under reduced pressure
Method, temperature are 30~60 DEG C, and concentration relative density is 1.0~1.2, and drying means is 140~180 DEG C of spray drying, or
20~60 DEG C of vacuum decompression dryings.
The cherry powder that the present invention is prepared according to the above method is for controlling diabetes.
The present invention due to using preparation method, not only obtained can with expelling wind and eliminating dampness, the cherry wine of promoting blood circulation and stopping pain, moreover,
During the fermentation, other nutrition of fresh cherry are not had in the case of destroying, the part sugar that will contain in fresh cherry
Become alcohol by conversion to be precipitated, obtain that diabetes patient can courageously eat full of nutrition and can promote insulin generation,
Reduce the cherry powder of blood glucose, the present invention have simple for process, comprehensive utilization raw material, product is more, high income, it is at low cost, be suitable for advising
The advantages that modelling produces has bioactivity outstanding and pharmacological action in treatment diabetes, prevention and cure of cardiovascular disease etc.,
The present invention is suitable for the fields such as food, health products.
Specific implementation mode
With reference to embodiment, the present invention is further described：
A kind of preparation method of the cherry powder of control diabetes, it is characterised in that the preparation process of cherry powder include broken, fermentation,
Distillation, parsing-desiccation,
Wherein, the destruction step：Take fresh cherry, cherry cleans up rear drained, is put into crusher and is broken
Broken processing；
The fermentation step：It will first be activated at 45~50 DEG C of biological enzyme, into broken cherry plus biological enzyme is cherry fresh fruit
The 1-2 ‰ of weight, with citric acid tune pH value to 3.0-3.5, sugared additive amount is 15-20%, and when enzymolysis, enzyme activity requires to exist in solution
More than 5000 units, fermentation temperature is 20~30 DEG C, and fermentation time is 1~8 day, and inoculum of dry yeast is 0.1~0.5 ‰, hair
Citric acid or tartaric acid may be used in the adjustment of zymotic fluid pH value；
The distilation steps：Cherry former wine fermentation liquid is placed in vacuum distillation pot and is distilled, 1h is distilled, by cherry former wine
After alcohol in fermentation liquid all distills proposition, cherry schlempe solution and Spirit, the pressure of vacuum distillation therein are obtained
For -0.01~-0.1mpa, heating temperature may be provided within the scope of 30~60 DEG C；
The parsing-desiccation step：Cherry schlempe solution is adsorbed by macroporous absorbent resin, macroporous absorbent resin is washed with water
Afterwards, then with alcoholic solution it parses, obtains desorbed solution, macroporous absorbent resin is non-polar resin, or low pole resin, then will solution
The concentration of liquid low temperature is analysed, vacuum decompression drying, wherein the low temperature method for concentration of desorbed solution are normal pressure, or method is recovered under reduced pressure,
It is 30~60 DEG C that method temperature, which is recovered under reduced pressure, and concentration relative density is 1.0~1.2, and drying means is that 140~180 DEG C of sprayings are dry
Dry or 20~60 DEG C of vacuum decompression dryings, obtain cherry powder.
Biological enzyme of the present invention be pectase, cellulase, xylosidase, carbohydrase it is one or more.
The cherry powder that the present invention is prepared according to the above method is for controlling diabetes.
Embodiment 1：Take cherry fresh fruit 5kg, attrition crushing, activated cellulose enzyme at 45~50 DEG C, it is cherry to add cellulase
The 1 ‰ of peach fresh fruit weight, with citric acid tune pH value to 3.5, sugared additive amount is 15%, and inoculum of dry yeast is 0.2 ‰, fermentation temperature
It it is 20~27 DEG C, fermentation time is to obtain cherry former wine fermentation liquid after 5 days, and it is whole that cherry former wine fermentation liquid is put into decompression
1h is distilled in reason vessel, pressure is -0.05mpa, and heating temperature is 30~60 DEG C, obtains cherry schlempe solution and Spirit, will
Cherry schlempe solution is adsorbed by macroporous absorbent resin, after macroporous absorbent resin is washed with water, is parsed, is parsed with alcoholic solution
Liquid, after desorbed solution is concentrated under reduced pressure into relative density 1.1,40 DEG C of vacuum decompression dryings obtain cherry powder 22.1g, and yield is fresh
The 0.44% of fruit weight obtains 60% cherry Spirit 503ml.
Embodiment 2：Take cherry fresh fruit 5kg, attrition crushing activates pectase at 45~50 DEG C, and it is that cherry is fresh to add pectase
The 2 ‰ of fruit weight, with tartaric acid tune pH value to 3.0, sugared additive amount is 15%, and inoculum of dry yeast is 0.3 ‰, fermentation temperature 25
~30 DEG C, fermentation time is to obtain cherry former wine fermentation liquid after 6 days, cherry former wine fermentation liquid is put into decompression reorganizer
1h is distilled in ware, pressure is -0.06mpa, and heating temperature is 30~60 DEG C, cherry schlempe solution and Spirit is obtained, by cherry
Schlempe solution is adsorbed by macroporous absorbent resin, after macroporous absorbent resin is washed with water, is parsed with alcoholic solution, is obtained desorbed solution,
After desorbed solution is concentrated under reduced pressure into relative density 1.2,45 DEG C of vacuum decompression dryings obtain cherry powder 24.2g, and yield is fresh fruit weight
The 0.48% of amount, obtains 60% cherry Spirit 510ml.
Embodiment 3：Take cherry fresh fruit 5kg, attrition crushing, activated cellulose enzyme and pectase at 45~50 DEG C add fiber
Plain enzyme is the 1 ‰ of cherry fresh fruit weight, and it is the 2 ‰ of cherry fresh fruit weight to add pectase, and with citric acid tune pH value to 3.5, sugar adds
Dosage is 20%, and inoculum of dry yeast is 0.25 ‰, and fermentation temperature is 25~30 DEG C, and fermentation time is to obtain cherry former wine after 8 days
Cherry former wine fermentation liquid is put into decompression and arranged and distills 1h in vessel by fermentation liquid, and pressure is -0.06mpa, and heating temperature is
30~60 DEG C, cherry schlempe solution and Spirit are obtained, cherry schlempe solution is adsorbed by macroporous absorbent resin, is washed with water
It after macroporous absorbent resin, is parsed with alcoholic solution, obtains desorbed solution, after desorbed solution is concentrated under reduced pressure into relative density 1.1,50 DEG C true
Sky is dried under reduced pressure, and obtains cherry powder 25.1g, and yield is the 0.50% of fresh fruit weight, obtains 60% cherry Spirit 524ml.
The present invention does further detailed description by following tests proof to the present invention：
1 case selection：10 diabetics are chosen, are voluntarily participated in 10 diabetics tested, medical history is longest to be reached
42 years, shortest 6 years, during participating in experiment, it is desirable that diet keeps relative equilibrium, the medication of embodiment 1 adding cherry
The dosage of insulin detemir was reduced into 2 units in the 6th day after capsule prepared by powder, remaining medication does not adjust, takes cherry powder
Know from experience after capsule：Hypoglycemic reaction symptom disappears, and edematous condition is alleviated significantly, and sleep quality is obviously improved.
2 eating methods：Three times a day, 5 tablets each time（Daily 15, it is equivalent to cherry fresh fruit 1000g）, in addition, following subordinate list
In the method for taking cherry powder capsule of embodiment 8 be every night 15 it is primary oral.
4 therapeutic effects：Please refer to following table
As a result total effective rate is 100%.
Preparation method of the present invention, not only obtained can with expelling wind and eliminating dampness, the cherry wine of promoting blood circulation and stopping pain, moreover,
During the fermentation, since other nutrition of fresh cherry do not destroy, the part sugar contained in fresh cherry is led to
It crosses conversion and becomes alcohol precipitation, obtain that diabetes patient can courageously eat full of nutrition and insulin can be promoted to generate, drop
The cherry powder of hypoglycemia, the present invention have simple for process, comprehensive utilization raw material, product is more, high income, it is at low cost, suitable for scale
The advantages that metaplasia is produced has bioactivity outstanding and pharmacological action in treatment diabetes, prevention and cure of cardiovascular disease etc., this
Invention is suitable for the fields such as food, health products.
Claims (7)
1. a kind of preparation method of the cherry powder of control diabetes, it is characterised in that the preparation process of cherry powder includes broken, hair
Ferment, distillation, parsing, drying；
Wherein, the destruction step：Take fresh cherry, cherry cleans up rear drained, is put into crusher and is broken
Broken processing；
The fermentation step：Biological enzyme is added into broken cherry to be digested, after enzymolysis, is stood sealing and fermenting,
Obtain cherry former wine fermentation liquid；
The distilation steps：Cherry former wine fermentation liquid is placed in vacuum distillation pot and is distilled, cherry former wine is fermented molten
After alcohol in liquid all distills proposition, cherry schlempe solution and Spirit are obtained；
The parsing-desiccation step：Cherry schlempe solution is adsorbed by macroporous absorbent resin, macroporous absorbent resin is washed with water
Afterwards, then with alcoholic solution it parses, obtains desorbed solution, then desorbed solution low temperature is concentrated, vacuum decompression drying obtains cherry powder.
2. a kind of preparation method of the cherry powder of control diabetes according to claim 1, it is characterised in that the fermentation
Biological enzyme in step be pectase, cellulase, xylosidase, carbohydrase it is one or more, when enzymolysis, enzyme activity requires to exist
It is more than 5000 units.
3. a kind of preparation method of the cherry powder of control diabetes according to claim 1, it is characterised in that the fermentation
Fermentation temperature in step is at 20~30 DEG C, and fermentation time can be 1~8 day, and inoculum of dry yeast is 0.1~0.5 ‰, zymotic fluid PH
The adjustment of value uses citric acid or tartaric acid.
4. a kind of preparation method of the cherry powder of control diabetes according to claim 1, it is characterised in that the distillation
When vacuum distillation in step, pressure is -0.01~-0.1mpa, and heating temperature is arranged within the scope of 30~60 DEG C.
5. a kind of preparation method of the cherry powder of control diabetes according to claim 1, it is characterised in that the parsing
The low temperature method for concentration of desorbed solution in drying steps is recovered under reduced pressure method, and temperature is 30~60 DEG C, and concentration relative density is 1.0~
1.2, drying means is 140~180 DEG C of spray drying.
6. a kind of preparation method of the cherry powder of control diabetes according to claim 1, it is characterised in that the parsing
The low temperature method for concentration of desorbed solution in drying steps is recovered under reduced pressure method, and temperature is 30~60 DEG C, and concentration relative density is 1.0~
1.2, drying means is that 20~60 DEG C of vacuum decompressions are dried.
7. prepared by a kind of preparation method of the cherry powder of control diabetes according to the claims 1,2,3,4,5 or 6
Cherry powder for controlling diabetes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810731443.6A CN108785411A (en) | 2018-07-05 | 2018-07-05 | A kind of Preparation method and use of the cherry powder of control diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810731443.6A CN108785411A (en) | 2018-07-05 | 2018-07-05 | A kind of Preparation method and use of the cherry powder of control diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108785411A true CN108785411A (en) | 2018-11-13 |
Family
ID=64075120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810731443.6A Pending CN108785411A (en) | 2018-07-05 | 2018-07-05 | A kind of Preparation method and use of the cherry powder of control diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108785411A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111713700A (en) * | 2020-07-15 | 2020-09-29 | 沈阳膳源善食生物科技有限公司 | A food composition |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104892700A (en) * | 2015-06-11 | 2015-09-09 | 威海紫光科技园有限公司 | Method for extracting anthocyanin from cherries |
-
2018
- 2018-07-05 CN CN201810731443.6A patent/CN108785411A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104892700A (en) * | 2015-06-11 | 2015-09-09 | 威海紫光科技园有限公司 | Method for extracting anthocyanin from cherries |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111713700A (en) * | 2020-07-15 | 2020-09-29 | 沈阳膳源善食生物科技有限公司 | A food composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105559089A (en) | Liver-protecting and toxin-expelling fruit and vegetable enzyme and preparation method thereof | |
| CN105124589A (en) | Integrated enzyme and preparation method thereof | |
| CN101928745A (en) | Preparation method and applications of ant polypeptide | |
| CN104256584A (en) | Moringa oleifera ferment and preparation method thereof | |
| CN104187682A (en) | Preparation technology for blood-sugar-reducing health Chinese herbal gluten peptides | |
| CN106244371B (en) | A kind of hypoglycemic rhizoma polygonati grape health care wine and its production technology | |
| CN101724667A (en) | Technology for extracting dendrobium polysaccharide by applying biology engineering enzyme technology and product thereof and application | |
| CN108552491A (en) | Compound vinegar egg juice and preparation method thereof with lower hyperlipidemia, hypertension, hyperglycemia illness function | |
| CN106418525A (en) | Fermenting folium mori chewable tablet and preparation method thereof | |
| CN107164446A (en) | The preparation method and its antifatigue effect of deer hemepeptide | |
| CN106721855A (en) | A kind of solid beverage preparation method for safeguarding men's health | |
| CN104388236B (en) | A kind of grape wine and preparation method and application | |
| CN105661554A (en) | Silkworm chrysalis small molecule peptide chelate for improving immunity and preparation method thereof | |
| CN110862897A (en) | Mulberry leaf and silkworm chrysalis yellow wine and its making process | |
| CN110547447A (en) | Royal jelly collagen fruit enzyme and preparation method thereof | |
| CN108902853A (en) | A kind of method of honey concentration | |
| CN113383950A (en) | Bitter gourd health food | |
| CN108323600A (en) | A kind of health care ferment tea solid electuary and its production method | |
| CN108785411A (en) | A kind of Preparation method and use of the cherry powder of control diabetes | |
| CN107212392A (en) | A kind of full nutrition fermentation health-preserving food and preparation method thereof | |
| CN104739964B (en) | A kind of snail sobering preparation and preparation method thereof | |
| CN103952259B (en) | A kind of preparation method of red bean red date bee honey health-care wine | |
| CN107648287B (en) | Young chicken paste ointment and application thereof in preparation of medicine for treating cracked nipple of lying-in woman | |
| CN107794156A (en) | A kind of preparation method of morat | |
| CN114010750A (en) | Ginseng and grass formula for tonifying kidney, generating blood and resisting aging |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20181113 |